Free Trial

TerrAscend Q4 2024 Earnings Report

TerrAscend logo
$0.46 -0.02 (-3.97%)
As of 04/1/2025 03:54 PM Eastern

TerrAscend EPS Results

Actual EPS
$0.01
Consensus EPS
-$0.03
Beat/Miss
Beat by +$0.04
One Year Ago EPS
N/A

TerrAscend Revenue Results

Actual Revenue
$74.35 million
Expected Revenue
$72.37 million
Beat/Miss
Beat by +$1.98 million
YoY Revenue Growth
N/A

TerrAscend Announcement Details

Quarter
Q4 2024
Time
After Market Closes
Remove Ads

TerrAscend Earnings Headlines

Critical Review: TerrAscend (TSNDF) & The Competition
Head to Head Comparison: TerrAscend (TSNDF) & Its Peers
DOGE Social Security bombshell?
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social Security, finding what he says is widespread fraud across the agency.
Analyzing TerrAscend (TSNDF) and Its Competitors
Head to Head Survey: TerrAscend (TSNDF) & The Competition
TerrAscend (TSNDF) & Its Competitors Head-To-Head Analysis
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

View TerrAscend Profile

More Earnings Resources from MarketBeat